Antigen-Specific T Cell Detection in Cerebrospinal Fluid
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current diagnostic methods for central nervous system (CNS) infections, such as those caused by alpha herpes viruses, face challenges due to the late or absent appearance of typical signs, high false negative rates in PCR tests, and difficulties in detecting antigen-specific T cells in small sample volumes like cerebrospinal fluid, leading to inadequate infection monitoring and therapy management.
Innovation Solution
A new diagnostic method involving the simultaneous stimulation of antigen-specific T cells from extrasanguine and whole blood samples using fluorochrome-coupled CD45 antibodies to differentiate and quantify T cells, enabling sensitive analysis and monitoring of antigen-specific responses in CNS infections and other pathogen-related conditions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If antigen-specific T cells are detected directly in extrasanguine fluids (e.g., CSF), then the diagnostic accuracy for CNS infections is improved, but the detection sensitivity is reduced due to low cell numbers and limited sample volume
Solution Approach 1:
The patent combines extrasanguine cells (from CSF or other body fluids) with whole blood cells in a single stimulation reaction. This merging allows antigen-specific T cells from the extrasanguine fluid to be activated and detected alongside blood T cells, overcoming the limitation of low cell numbers in small sample volumes while maintaining diagnostic accuracy for CNS infections
Solution Approach 2:
The patent uses fluorochrome-coupled CD45 antibodies as a marker to distinguish between extrasanguine T cells and blood T cells during flow cytometry analysis. This intermediary marker enables selective identification and quantification of antigen-specific T cells from the extrasanguine fluid within the mixed cell population, ensuring accurate detection despite the combined sample
2Measurement precision
If separate stimulation reactions are performed for extrasanguine and blood samples, then the antigen-specific T cell response can be analyzed, but the procedural complexity and time required increase
Solution Approach 1:
The patent merges the stimulation of extrasanguine cells and whole blood cells into a single reaction well, using the same antigen stimulator and cytokine conditions. This combined approach maintains the ability to analyze antigen-specific T cell responses while significantly reducing procedural steps, reagent consumption, and analysis time compared to performing separate stimulation reactions
3Measurement precision
If PCR is used as the gold standard for pathogen detection in cerebrospinal fluid, then direct pathogen detection is achieved, but false negative results occur due to limited detection time span
Solution Approach 1:
The patent uses antigen-specific T cells as an intermediary indicator of active infection. Instead of directly detecting the pathogen (which may be present in low amounts or transiently), the method detects the host's immune response to the pathogen through antigen-specific T cell activation and cytokine production. This indirect detection method extends the diagnostic window beyond the limited time span in which viruses can be directly detected by PCR
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enhances the sensitivity and accuracy of antigen-specific T cell detection, allowing for effective monitoring of CNS infections and treatment success, and can be applied to various pathogens and autoimmune diseases, overcoming limitations in small sample volumes and low cell numbers.
Implementation Method 1
all extrasanguine cells are stained with a fluorochrome-coupled CD45 antibody before they are mixed with the blood cells
Implementation Method 2
The quantification of antigen-specific immune responses is based on the specific cytokine induction of T lymphocytes after stimulation
Data Source
Figure 1A~1C
Figure 2A~2C
Figure 3A~3D
AI summary
The invention relates to a stimulation-based process for the detection of antigen-specific immune cells in extrasanguine fluids. Since the components necessary for the stimulation of immune cells are available only to a limited extent therein, this detection has up to now not been possible or at least been limited. In the new method, extrasanguine samples and whole blood samples from the same person are mixed and then stimulated with antigen. As a result, the components necessary for the stimulation are provided by the whole blood. This brings about, in the antigen-specific immune cells, cytokine induction, by means of which the immune cells can be identified. The special feature is that all extrasanguine cells are dyed with a fluorochrome or fluorochrome-coupled antibody before they are mixed with the blood cells. As a result, in the final analysis, immune cells from the blood and from the extrasanguine fluid can be differentiated on the basis of the absence or the presence of this fluorescence signal.